,index,gene,pagerank_score,source_disease,ensembl_gene_id,druggability_tier,hgnc_names,chr_b37,start_b37,end_b37,strand,description,no_of_gwas_regions,small_mol_druggable,bio_druggable,adme_gene
0,0,FYN,0.0564525804200281,PD,ENSG00000010810,Tier 1,FYN,6,111981535.0,112194655.0,-1.0,"FYN oncogene related to SRC, FGR, YES [Source:HGNC Symbol;Acc:4037]",1.0,1.0,1.0,1.0
0,0,FYN,0.0564525804200281,SCZ,ENSG00000010810,Tier 1,FYN,6,111981535.0,112194655.0,-1.0,"FYN oncogene related to SRC, FGR, YES [Source:HGNC Symbol;Acc:4037]",1.0,1.0,1.0,1.0
1,1,CXCR4,0.0198942424528421,MS,ENSG00000121966,Tier 1,CXCR4,2,136871919.0,136875735.0,-1.0,chemokine (C-X-C motif) receptor 4 [Source:HGNC Symbol;Acc:2561],0.0,1.0,1.0,1.0
2,2,STAT3,0.019722984222456,MS,ENSG00000168610,Tier 1,STAT3,17,40465342.0,40540586.0,-1.0,signal transducer and activator of transcription 3 (acute-phase response factor) [Source:HGNC Symbol;Acc:11364],6.0,1.0,1.0,1.0
3,3,TNFRSF1A,0.0124572730330199,MS,ENSG00000067182,Tier 1,TNFRSF1A,12,6437923.0,6451280.0,-1.0,"tumor necrosis factor receptor superfamily, member 1A [Source:HGNC Symbol;Acc:11916]",3.0,1.0,1.0,1.0
4,4,BMPR1B,0.0095887452384463,SCZ,ENSG00000138696,Tier 1,BMPR1B,4,95679119.0,96079599.0,1.0,"bone morphogenetic protein receptor, type IB [Source:HGNC Symbol;Acc:1077]",0.0,1.0,1.0,1.0
5,5,LRP1,0.0086517878259959,MigraineDisorder,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,1.0,1.0,1.0
6,6,ITGB5,0.0086426552821295,MigraineDisorder,ENSG00000082781,Tier 1,ITGB5,3,124480795.0,124620265.0,-1.0,"integrin, beta 5 [Source:HGNC Symbol;Acc:6160]",0.0,1.0,1.0,1.0
7,7,NGF,0.0081797839501774,MigraineDisorder,ENSG00000134259,Tier 1,NGF,1,115828539.0,115880857.0,-1.0,nerve growth factor (beta polypeptide) [Source:HGNC Symbol;Acc:7808],0.0,1.0,1.0,1.0
8,8,RELN,0.0079996841582723,RestlessLeg,ENSG00000189056,Tier 3A,RELN,7,103112231.0,103629963.0,-1.0,reelin [Source:HGNC Symbol;Acc:9957],1.0,1.0,1.0,1.0
9,9,DPP4,0.0077338368495669,AD,ENSG00000197635,Tier 1,DPP4,2,162848751.0,162931052.0,-1.0,dipeptidyl-peptidase 4 [Source:HGNC Symbol;Acc:3009],2.0,1.0,1.0,1.0
9,9,DPP4,0.0077338368495669,SCZ,ENSG00000197635,Tier 1,DPP4,2,162848751.0,162931052.0,-1.0,dipeptidyl-peptidase 4 [Source:HGNC Symbol;Acc:3009],2.0,1.0,1.0,1.0
10,10,SNCA,0.0076904934011844,LBD,ENSG00000145335,Tier 2,SNCA,4,90645250.0,90759466.0,-1.0,"synuclein, alpha (non A4 component of amyloid precursor) [Source:HGNC Symbol;Acc:11138]",13.0,1.0,1.0,1.0
10,10,SNCA,0.0076904934011844,PD,ENSG00000145335,Tier 2,SNCA,4,90645250.0,90759466.0,-1.0,"synuclein, alpha (non A4 component of amyloid precursor) [Source:HGNC Symbol;Acc:11138]",13.0,1.0,1.0,1.0
10,10,SNCA,0.0076904934011844,SCZ,ENSG00000145335,Tier 2,SNCA,4,90645250.0,90759466.0,-1.0,"synuclein, alpha (non A4 component of amyloid precursor) [Source:HGNC Symbol;Acc:11138]",13.0,1.0,1.0,1.0
11,11,NRP1,0.0073227245863569,MigraineDisorder,ENSG00000099250,Tier 1,NRP1,10,33466420.0,33625190.0,-1.0,neuropilin 1 [Source:HGNC Symbol;Acc:8004],0.0,1.0,1.0,1.0
13,13,ACVR1B,0.0070925908273591,Epilepsy,ENSG00000135503,Tier 1,ACVR1B,12,52345451.0,52390862.0,1.0,"activin A receptor, type IB [Source:HGNC Symbol;Acc:172]",0.0,1.0,1.0,1.0
13,13,ACVR1B,0.0070925908273591,MajorDepressiveDisorder,ENSG00000135503,Tier 1,ACVR1B,12,52345451.0,52390862.0,1.0,"activin A receptor, type IB [Source:HGNC Symbol;Acc:172]",0.0,1.0,1.0,1.0
14,14,IL6R,0.0069193387035759,AD,ENSG00000160712,Tier 1,IL6R,1,154377669.0,154441926.0,1.0,interleukin 6 receptor [Source:HGNC Symbol;Acc:6019],9.0,1.0,1.0,1.0
15,15,TLR4,0.0067728234026778,MajorDepressiveDisorder,ENSG00000136869,Tier 2,TLR4,9,120466610.0,120479149.0,1.0,toll-like receptor 4 [Source:HGNC Symbol;Acc:11850],0.0,1.0,1.0,1.0
16,16,IFNGR2,0.0065465353319326,MS,ENSG00000159128,Tier 1,IFNGR2,21,34775202.0,34851655.0,1.0,interferon gamma receptor 2 (interferon gamma transducer 1) [Source:HGNC Symbol;Acc:5440],2.0,1.0,1.0,1.0
17,17,EFNA5,0.0061021344814975,MajorDepressiveDisorder,ENSG00000184349,Tier 3A,EFNA5,5,106712590.0,107006596.0,-1.0,ephrin-A5 [Source:HGNC Symbol;Acc:3225],0.0,1.0,1.0,1.0
17,17,EFNA5,0.0061021344814975,SCZ,ENSG00000184349,Tier 3A,EFNA5,5,106712590.0,107006596.0,-1.0,ephrin-A5 [Source:HGNC Symbol;Acc:3225],0.0,1.0,1.0,1.0
19,19,ITGA8,0.0059003994423237,PD,ENSG00000077943,Tier 3A,ITGA8,10,15555948.0,15762124.0,-1.0,"integrin, alpha 8 [Source:HGNC Symbol;Acc:6144]",0.0,1.0,1.0,1.0
21,21,APOB,0.0051141324849353,AD,ENSG00000084674,Tier 1,APOB,2,21224301.0,21266945.0,-1.0,apolipoprotein B [Source:HGNC Symbol;Acc:603],36.0,1.0,1.0,1.0
22,22,WNT4,0.0050673455714935,SCZ,ENSG00000162552,Tier 3A,WNT4,1,22443798.0,22470462.0,-1.0,"wingless-type MMTV integration site family, member 4 [Source:HGNC Symbol;Acc:12783]",11.0,1.0,1.0,1.0
23,23,IL7R,0.004993666387761,MS,ENSG00000168685,Tier 3A,IL7R,5,35852797.0,35879705.0,1.0,interleukin 7 receptor [Source:HGNC Symbol;Acc:6024],4.0,1.0,1.0,1.0
24,24,IL12A,0.0049402669768785,Epilepsy,ENSG00000168811,Tier 3A,IL12A,3,159706537.0,159713806.0,1.0,"interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) [Source:HGNC Symbol;Acc:5969]",2.0,1.0,1.0,1.0
24,24,IL12A,0.0049402669768785,MS,ENSG00000168811,Tier 3A,IL12A,3,159706537.0,159713806.0,1.0,"interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) [Source:HGNC Symbol;Acc:5969]",2.0,1.0,1.0,1.0
26,26,ERBB4,0.004907657524283,MajorDepressiveDisorder,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,1.0
28,28,PTN,0.0045182148253269,MajorDepressiveDisorder,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,1.0,1.0,1.0
28,28,PTN,0.0045182148253269,SCZ,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,1.0,1.0,1.0
29,29,PTK2B,0.0045174981713164,AD,ENSG00000120899,Tier 1,PTK2B,8,27168999.0,27316903.0,1.0,protein tyrosine kinase 2 beta [Source:HGNC Symbol;Acc:9612],1.0,1.0,1.0,1.0
29,29,PTK2B,0.0045174981713164,MigraineDisorder,ENSG00000120899,Tier 1,PTK2B,8,27168999.0,27316903.0,1.0,protein tyrosine kinase 2 beta [Source:HGNC Symbol;Acc:9612],1.0,1.0,1.0,1.0
30,30,CALCB,0.0044123616970599,MigraineDisorder,ENSG00000175868,Tier 3A,CALCB,11,14926543.0,15103888.0,1.0,calcitonin-related polypeptide beta [Source:HGNC Symbol;Acc:1438],4.0,1.0,1.0,1.0
31,31,NECTIN2,0.0043939023089224,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
31,31,NECTIN2,0.0043939023089224,LBD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
32,32,ESR1,0.0043896533176271,MajorDepressiveDisorder,ENSG00000091831,Tier 1,ESR1,6,151977826.0,152450754.0,1.0,estrogen receptor 1 [Source:HGNC Symbol;Acc:3467],14.0,1.0,1.0,1.0
33,33,NRXN1,0.004305362768983,AD,ENSG00000179915,Tier 3A,NRXN1,2,50145643.0,51259674.0,-1.0,neurexin 1 [Source:HGNC Symbol;Acc:8008],0.0,1.0,1.0,1.0
33,33,NRXN1,0.004305362768983,MajorDepressiveDisorder,ENSG00000179915,Tier 3A,NRXN1,2,50145643.0,51259674.0,-1.0,neurexin 1 [Source:HGNC Symbol;Acc:8008],0.0,1.0,1.0,1.0
34,34,APOE,0.0040915853088913,AD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,1.0,1.0,1.0
34,34,APOE,0.0040915853088913,LBD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,1.0,1.0,1.0
34,34,APOE,0.0040915853088913,MajorDepressiveDisorder,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,1.0,1.0,1.0
34,34,APOE,0.0040915853088913,PD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,1.0,1.0,1.0
34,34,APOE,0.0040915853088913,SCZ,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,1.0,1.0,1.0
37,37,FGF20,0.0038185720603465,PD,ENSG00000078579,Tier 3B,FGF20,8,16849678.0,16859690.0,-1.0,fibroblast growth factor 20 [Source:HGNC Symbol;Acc:3677],0.0,1.0,1.0,1.0
38,38,STAT6,0.0037889419829804,MajorDepressiveDisorder,ENSG00000166888,Tier 2,STAT6,12,57489191.0,57525922.0,-1.0,"signal transducer and activator of transcription 6, interleukin-4 induced [Source:HGNC Symbol;Acc:11368]",8.0,1.0,1.0,1.0
38,38,STAT6,0.0037889419829804,MigraineDisorder,ENSG00000166888,Tier 2,STAT6,12,57489191.0,57525922.0,-1.0,"signal transducer and activator of transcription 6, interleukin-4 induced [Source:HGNC Symbol;Acc:11368]",8.0,1.0,1.0,1.0
38,38,STAT6,0.0037889419829804,SCZ,ENSG00000166888,Tier 2,STAT6,12,57489191.0,57525922.0,-1.0,"signal transducer and activator of transcription 6, interleukin-4 induced [Source:HGNC Symbol;Acc:11368]",8.0,1.0,1.0,1.0
39,39,CNTN1,0.0037377451179535,PD,ENSG00000018236,Tier 3A,CNTN1,12,41086244.0,41466220.0,1.0,contactin 1 [Source:HGNC Symbol;Acc:2171],1.0,1.0,1.0,1.0
40,40,FGF6,0.0036079353022027,MigraineDisorder,ENSG00000111241,Tier 3B,FGF6,12,4537321.0,4554780.0,-1.0,fibroblast growth factor 6 [Source:HGNC Symbol;Acc:3684],0.0,1.0,1.0,1.0
41,41,APP,0.0034884788088614,AD,ENSG00000142192,Tier 1,APP,21,27252861.0,27543446.0,-1.0,amyloid beta (A4) precursor protein [Source:HGNC Symbol;Acc:620],0.0,1.0,1.0,1.0
42,42,PILRA,0.0034330640184512,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
43,43,WNT7B,0.0034242043216302,MajorDepressiveDisorder,ENSG00000188064,Tier 3A,WNT7B,22,46316242.0,46373009.0,-1.0,"wingless-type MMTV integration site family, member 7B [Source:HGNC Symbol;Acc:12787]",0.0,1.0,1.0,1.0
44,44,WNT3,0.003421010713609,PD,ENSG00000108379,Tier 2,WNT3,17,44839872.0,44910520.0,-1.0,"wingless-type MMTV integration site family, member 3 [Source:HGNC Symbol;Acc:12782]",13.0,1.0,1.0,1.0
46,46,TGFB1,0.0032172016648887,AD,ENSG00000105329,Tier 1,TGFB1,19,41807492.0,41859816.0,-1.0,"transforming growth factor, beta 1 [Source:HGNC Symbol;Acc:11766]",1.0,1.0,1.0,1.0
46,46,TGFB1,0.0032172016648887,MigraineDisorder,ENSG00000105329,Tier 1,TGFB1,19,41807492.0,41859816.0,-1.0,"transforming growth factor, beta 1 [Source:HGNC Symbol;Acc:11766]",1.0,1.0,1.0,1.0
47,47,PRKD1,0.0031516901943885,MajorDepressiveDisorder,ENSG00000184304,Tier 1,PRKD1,14,30045687.0,30661104.0,-1.0,protein kinase D1 [Source:HGNC Symbol;Acc:9407],2.0,1.0,1.0,1.0
47,47,PRKD1,0.0031516901943885,MS,ENSG00000184304,Tier 1,PRKD1,14,30045687.0,30661104.0,-1.0,protein kinase D1 [Source:HGNC Symbol;Acc:9407],2.0,1.0,1.0,1.0
47,47,PRKD1,0.0031516901943885,SCZ,ENSG00000184304,Tier 1,PRKD1,14,30045687.0,30661104.0,-1.0,protein kinase D1 [Source:HGNC Symbol;Acc:9407],2.0,1.0,1.0,1.0
48,48,DCC,0.0031509448493008,AnorexiaNervosa,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,DCC,0.0031509448493008,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,DCC,0.0031509448493008,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,DCC,0.0031509448493008,OCD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,DCC,0.0031509448493008,SCZ,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,DCC,0.0031509448493008,Tourette,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
49,49,FSTL5,0.0030691608214842,BipolarDisorder,ENSG00000168843,Tier 3A,FSTL5,4,162305049.0,163085187.0,-1.0,follistatin-like 5 [Source:HGNC Symbol;Acc:21386],0.0,1.0,1.0,1.0
53,53,MAP3K14,0.0028363364896286,MS,ENSG00000006062,Tier 2,MAP3K14,17,43340488.0,43394414.0,-1.0,mitogen-activated protein kinase kinase kinase 14 [Source:HGNC Symbol;Acc:6853],0.0,1.0,1.0,1.0
54,54,TGFBR2,0.0028034468274446,MigraineDisorder,ENSG00000163513,Tier 1,TGFBR2,3,30647994.0,30735634.0,1.0,"transforming growth factor, beta receptor II (70/80kDa) [Source:HGNC Symbol;Acc:11773]",1.0,1.0,1.0,1.0
57,57,IL2RA,0.0027116841073674,MS,ENSG00000134460,Tier 1,IL2RA,10,6052652.0,6104288.0,-1.0,"interleukin 2 receptor, alpha [Source:HGNC Symbol;Acc:6008]",16.0,1.0,1.0,1.0
58,58,TNFSF14,0.0026762637078537,MS,ENSG00000125735,Tier 1,TNFSF14,19,6663148.0,6670599.0,-1.0,"tumor necrosis factor (ligand) superfamily, member 14 [Source:HGNC Symbol;Acc:11930]",1.0,1.0,1.0,1.0
61,61,PTPRD,0.0025014303887451,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
61,61,PTPRD,0.0025014303887451,RestlessLeg,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
61,61,PTPRD,0.0025014303887451,SCZ,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
62,62,SEMA3A,0.0024339543724975,MajorDepressiveDisorder,ENSG00000075213,Tier 3A,SEMA3A,7,83585093.0,84122040.0,-1.0,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A [Source:HGNC Symbol;Acc:10723]",1.0,1.0,1.0,1.0
64,64,GRIA1,0.0023871392248264,AD,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
64,64,GRIA1,0.0023871392248264,MajorDepressiveDisorder,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
64,64,GRIA1,0.0023871392248264,RestlessLeg,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
64,64,GRIA1,0.0023871392248264,SCZ,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
66,66,CD40,0.0022628513885853,BipolarDisorder,ENSG00000101017,Tier 1,CD40,20,44746911.0,44758502.0,1.0,"CD40 molecule, TNF receptor superfamily member 5 [Source:HGNC Symbol;Acc:11919]",7.0,1.0,1.0,1.0
66,66,CD40,0.0022628513885853,MajorDepressiveDisorder,ENSG00000101017,Tier 1,CD40,20,44746911.0,44758502.0,1.0,"CD40 molecule, TNF receptor superfamily member 5 [Source:HGNC Symbol;Acc:11919]",7.0,1.0,1.0,1.0
66,66,CD40,0.0022628513885853,MS,ENSG00000101017,Tier 1,CD40,20,44746911.0,44758502.0,1.0,"CD40 molecule, TNF receptor superfamily member 5 [Source:HGNC Symbol;Acc:11919]",7.0,1.0,1.0,1.0
66,66,CD40,0.0022628513885853,SCZ,ENSG00000101017,Tier 1,CD40,20,44746911.0,44758502.0,1.0,"CD40 molecule, TNF receptor superfamily member 5 [Source:HGNC Symbol;Acc:11919]",7.0,1.0,1.0,1.0
67,67,TGFBR3,0.0022017508990382,MS,ENSG00000069702,Tier 3A,TGFBR3,1,92145902.0,92371892.0,-1.0,"transforming growth factor, beta receptor III [Source:HGNC Symbol;Acc:11774]",0.0,1.0,1.0,1.0
68,68,CD47,0.0021956047071088,BipolarDisorder,ENSG00000196776,Tier 3B,CD47,3,107762145.0,107809872.0,-1.0,CD47 molecule [Source:HGNC Symbol;Acc:1682],0.0,1.0,1.0,1.0
72,72,NOS1,0.0021380353411536,MajorDepressiveDisorder,ENSG00000089250,Tier 1,NOS1,12,117645947.0,117889975.0,-1.0,nitric oxide synthase 1 (neuronal) [Source:HGNC Symbol;Acc:7872],0.0,1.0,1.0,1.0
72,72,NOS1,0.0021380353411536,RestlessLeg,ENSG00000089250,Tier 1,NOS1,12,117645947.0,117889975.0,-1.0,nitric oxide synthase 1 (neuronal) [Source:HGNC Symbol;Acc:7872],0.0,1.0,1.0,1.0
73,73,NMB,0.0021339357771717,AnorexiaNervosa,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,1.0,1.0,1.0
73,73,NMB,0.0021339357771717,BipolarDisorder,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,1.0,1.0,1.0
73,73,NMB,0.0021339357771717,MajorDepressiveDisorder,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,1.0,1.0,1.0
73,73,NMB,0.0021339357771717,OCD,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,1.0,1.0,1.0
73,73,NMB,0.0021339357771717,SCZ,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,1.0,1.0,1.0
73,73,NMB,0.0021339357771717,Tourette,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,1.0,1.0,1.0
74,74,GRN,0.0021229543956907,AD,ENSG00000030582,Tier 3A,GRN,17,42422614.0,42430470.0,1.0,granulin [Source:HGNC Symbol;Acc:4601],1.0,1.0,1.0,1.0
77,77,EPHA1,0.002015546956161,AD,ENSG00000146904,Tier 1,EPHA1,7,143087382.0,143105985.0,-1.0,EPH receptor A1 [Source:HGNC Symbol;Acc:3385],1.0,1.0,1.0,1.0
78,78,S1PR1,0.0020122497509774,PD,ENSG00000170989,Tier 1,S1PR1,1,101702444.0,101707074.0,1.0,sphingosine-1-phosphate receptor 1 [Source:HGNC Symbol;Acc:3165],0.0,1.0,1.0,1.0
79,79,NLGN1,0.0019972652496757,MajorDepressiveDisorder,ENSG00000169760,Tier 3B,NLGN1,3,173114074.0,174004434.0,1.0,neuroligin 1 [Source:HGNC Symbol;Acc:14291],0.0,1.0,1.0,1.0
79,79,NLGN1,0.0019972652496757,MigraineDisorder,ENSG00000169760,Tier 3B,NLGN1,3,173114074.0,174004434.0,1.0,neuroligin 1 [Source:HGNC Symbol;Acc:14291],0.0,1.0,1.0,1.0
79,79,NLGN1,0.0019972652496757,RestlessLeg,ENSG00000169760,Tier 3B,NLGN1,3,173114074.0,174004434.0,1.0,neuroligin 1 [Source:HGNC Symbol;Acc:14291],0.0,1.0,1.0,1.0
80,80,PTCH1,0.0019897518540602,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
80,80,PTCH1,0.0019897518540602,MigraineDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
83,83,MAPK1,0.0019757453465736,MS,ENSG00000100030,Tier 1,MAPK1,22,22108789.0,22221970.0,-1.0,mitogen-activated protein kinase 1 [Source:HGNC Symbol;Acc:6871],1.0,1.0,1.0,1.0
85,85,CRHR1,0.0019415432379518,MajorDepressiveDisorder,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,1.0
85,85,CRHR1,0.0019415432379518,MigraineDisorder,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,1.0
85,85,CRHR1,0.0019415432379518,PD,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,1.0
85,85,CRHR1,0.0019415432379518,SCZ,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,1.0
86,86,MAPK3,0.0019319519926951,MS,ENSG00000102882,Tier 1,MAPK3,16,30125426.0,30134827.0,-1.0,mitogen-activated protein kinase 3 [Source:HGNC Symbol;Acc:6877],1.0,1.0,1.0,1.0
89,89,MAP4K4,0.0018565881997868,PD,ENSG00000071054,Tier 1,MAP4K4,2,102313312.0,102511149.0,1.0,mitogen-activated protein kinase kinase kinase kinase 4 [Source:HGNC Symbol;Acc:6866],0.0,1.0,1.0,1.0
95,95,EPHA5,0.001722843360162,SCZ,ENSG00000145242,Tier 1,EPHA5,4,66185281.0,66536213.0,-1.0,EPH receptor A5 [Source:HGNC Symbol;Acc:3389],0.0,1.0,1.0,1.0
96,96,ADGRV1,0.001708962947054,SCZ,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
97,97,SEMA6D,0.0016896310719371,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
97,97,SEMA6D,0.0016896310719371,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
97,97,SEMA6D,0.0016896310719371,RestlessLeg,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
97,97,SEMA6D,0.0016896310719371,SCZ,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
104,104,SHANK2,0.0016237607616371,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
104,104,SHANK2,0.0016237607616371,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
105,105,NMUR2,0.0016237607616371,AnorexiaNervosa,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
105,105,NMUR2,0.0016237607616371,BipolarDisorder,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
105,105,NMUR2,0.0016237607616371,MajorDepressiveDisorder,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
105,105,NMUR2,0.0016237607616371,MigraineDisorder,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
105,105,NMUR2,0.0016237607616371,OCD,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
105,105,NMUR2,0.0016237607616371,SCZ,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
105,105,NMUR2,0.0016237607616371,Tourette,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,AD,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,AnorexiaNervosa,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,BipolarDisorder,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,MajorDepressiveDisorder,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,OCD,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,SCZ,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,Tourette,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
108,108,MERTK,0.0016198489337558,MS,ENSG00000153208,Tier 1,MERTK,2,112656056.0,112787138.0,1.0,c-mer proto-oncogene tyrosine kinase [Source:HGNC Symbol;Acc:7027],2.0,1.0,1.0,1.0
110,110,PTPRG,0.0016161984905377,MajorDepressiveDisorder,ENSG00000144724,Tier 3A,PTPRG,3,61547243.0,62283288.0,1.0,"protein tyrosine phosphatase, receptor type, G [Source:HGNC Symbol;Acc:9671]",0.0,1.0,1.0,1.0
116,116,IL2,0.0015189006191819,BipolarDisorder,ENSG00000109471,Tier 1,IL2,4,123372625.0,123377880.0,-1.0,interleukin 2 [Source:HGNC Symbol;Acc:6001],9.0,1.0,1.0,1.0
116,116,IL2,0.0015189006191819,MajorDepressiveDisorder,ENSG00000109471,Tier 1,IL2,4,123372625.0,123377880.0,-1.0,interleukin 2 [Source:HGNC Symbol;Acc:6001],9.0,1.0,1.0,1.0
117,117,PLCG1,0.001506117897673,MigraineDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
118,118,PLXNA4,0.0014785298068369,SCZ,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
125,125,GRIN2A,0.0014168017559012,AnorexiaNervosa,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
125,125,GRIN2A,0.0014168017559012,BipolarDisorder,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
125,125,GRIN2A,0.0014168017559012,MajorDepressiveDisorder,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
125,125,GRIN2A,0.0014168017559012,OCD,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
125,125,GRIN2A,0.0014168017559012,SCZ,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
125,125,GRIN2A,0.0014168017559012,Tourette,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
130,130,CLEC2D,0.001398716244002,MS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
131,131,DCLK3,0.0013733067671411,AnorexiaNervosa,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
131,131,DCLK3,0.0013733067671411,BipolarDisorder,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
131,131,DCLK3,0.0013733067671411,MajorDepressiveDisorder,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
131,131,DCLK3,0.0013733067671411,OCD,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
131,131,DCLK3,0.0013733067671411,SCZ,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
131,131,DCLK3,0.0013733067671411,Tourette,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,AnorexiaNervosa,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,BipolarDisorder,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,MajorDepressiveDisorder,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,OCD,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,SCZ,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,Tourette,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,AnorexiaNervosa,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,BipolarDisorder,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,MajorDepressiveDisorder,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,OCD,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,RestlessLeg,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,SCZ,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,Tourette,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
138,138,TREM2,0.0013627890688531,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
142,142,MMP3,0.0013529973029418,AD,ENSG00000149968,Tier 1,MMP3,11,102706532.0,102714534.0,-1.0,"matrix metallopeptidase 3 (stromelysin 1, progelatinase) [Source:HGNC Symbol;Acc:7173]",7.0,1.0,1.0,1.0
144,144,ABCB1,0.0013441201371739,SCZ,ENSG00000085563,Tier 1,ABCB1,7,87133175.0,87342611.0,-1.0,"ATP-binding cassette, sub-family B (MDR/TAP), member 1 [Source:HGNC Symbol;Acc:40]",0.0,1.0,1.0,1.0
145,145,INPP5D,0.0013432831408133,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
147,147,CD33,0.0013371602639826,AD,ENSG00000105383,Tier 1,CD33,19,51728320.0,51747115.0,1.0,CD33 molecule [Source:HGNC Symbol;Acc:1659],1.0,1.0,1.0,1.0
154,154,CD86,0.0012899747936994,MS,ENSG00000114013,Tier 1,CD86,3,121774213.0,121839983.0,1.0,CD86 molecule [Source:HGNC Symbol;Acc:1705],1.0,1.0,1.0,1.0
156,156,BDNF,0.001272272408102,RestlessLeg,ENSG00000176697,Tier 3A,BDNF,11,27676440.0,27743605.0,-1.0,brain-derived neurotrophic factor [Source:HGNC Symbol;Acc:1033],15.0,1.0,1.0,1.0
158,158,PLCG2,0.001264902704501,AD,ENSG00000197943,Tier 2,PLCG2,16,81772702.0,81991899.0,1.0,"phospholipase C, gamma 2 (phosphatidylinositol-specific) [Source:HGNC Symbol;Acc:9066]",0.0,1.0,1.0,1.0
159,159,FCGR2A,0.0012190366473683,PD,ENSG00000143226,Tier 3A,FCGR2A,1,161475220.0,161493803.0,1.0,"Fc fragment of IgG, low affinity IIa, receptor (CD32) [Source:HGNC Symbol;Acc:3616]",6.0,1.0,1.0,1.0
159,159,FCGR2A,0.0012190366473683,SCZ,ENSG00000143226,Tier 3A,FCGR2A,1,161475220.0,161493803.0,1.0,"Fc fragment of IgG, low affinity IIa, receptor (CD32) [Source:HGNC Symbol;Acc:3616]",6.0,1.0,1.0,1.0
162,162,CALCA,0.0012032627541918,MigraineDisorder,ENSG00000110680,Tier 1,CALCA,11,14988214.0,14993900.0,-1.0,calcitonin-related polypeptide alpha [Source:HGNC Symbol;Acc:1437],0.0,1.0,1.0,1.0
177,177,SCN1A,0.001120664190045,Epilepsy,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,1.0,1.0
178,178,SCN3A,0.001120664190045,MS,ENSG00000153253,Tier 1,SCN3A,2,165944032.0,166060577.0,-1.0,"sodium channel, voltage-gated, type III, alpha subunit [Source:HGNC Symbol;Acc:10590]",0.0,1.0,1.0,1.0
179,179,SCN2A,0.001120664190045,BipolarDisorder,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,1.0,1.0
183,183,SORL1,0.0011135857461024,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
184,184,MAPT,0.0011135857461024,AD,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
184,184,MAPT,0.0011135857461024,MajorDepressiveDisorder,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
184,184,MAPT,0.0011135857461024,PD,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
184,184,MAPT,0.0011135857461024,PSP,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
184,184,MAPT,0.0011135857461024,SCZ,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
187,187,LINGO1,0.0011135857461024,AD,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,1.0,1.0,1.0
187,187,LINGO1,0.0011135857461024,MajorDepressiveDisorder,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,1.0,1.0,1.0
187,187,LINGO1,0.0011135857461024,SCZ,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,1.0,1.0,1.0
191,191,CD58,0.0011028707332872,MS,ENSG00000116815,Tier 3A,CD58,1,117057157.0,117113661.0,-1.0,CD58 molecule [Source:HGNC Symbol;Acc:1688],3.0,1.0,1.0,1.0
196,196,CD6,0.0010803195384759,MS,ENSG00000013725,Tier 1,CD6,11,60739115.0,60787849.0,1.0,CD6 molecule [Source:HGNC Symbol;Acc:1691],3.0,1.0,1.0,1.0
198,198,LRFN5,0.0010703281086749,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
198,198,LRFN5,0.0010703281086749,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
204,204,PTPRF,0.0010429659664337,AnorexiaNervosa,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
204,204,PTPRF,0.0010429659664337,BipolarDisorder,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
204,204,PTPRF,0.0010429659664337,MajorDepressiveDisorder,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
204,204,PTPRF,0.0010429659664337,OCD,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
204,204,PTPRF,0.0010429659664337,SCZ,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
204,204,PTPRF,0.0010429659664337,Tourette,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
209,209,ANXA1,0.0010205731212064,SCZ,ENSG00000135046,Tier 3A,ANXA1,9,75766673.0,75785309.0,1.0,annexin A1 [Source:HGNC Symbol;Acc:533],0.0,1.0,1.0,1.0
217,217,BCL6,0.0009969677425211,MS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
220,220,TNFSF12,0.0009834777132456,MigraineDisorder,ENSG00000239697,Tier 1,TNFSF12,17,7452208.0,7464925.0,1.0,"tumor necrosis factor (ligand) superfamily, member 12 [Source:HGNC Symbol;Acc:11927]",19.0,1.0,1.0,1.0
222,222,LRP8,0.0009593072186026,SCZ,ENSG00000157193,Tier 3A,LRP8,1,53711217.0,53793742.0,-1.0,"low density lipoprotein receptor-related protein 8, apolipoprotein e receptor [Source:HGNC Symbol;Acc:6700]",1.0,1.0,1.0,1.0
225,225,IL22RA2,0.0009536241158102,Epilepsy,ENSG00000164485,Tier 3A,IL22RA2,6,137464968.0,137494785.0,-1.0,"interleukin 22 receptor, alpha 2 [Source:HGNC Symbol;Acc:14901]",0.0,1.0,1.0,1.0
225,225,IL22RA2,0.0009536241158102,MS,ENSG00000164485,Tier 3A,IL22RA2,6,137464968.0,137494785.0,-1.0,"interleukin 22 receptor, alpha 2 [Source:HGNC Symbol;Acc:14901]",0.0,1.0,1.0,1.0
226,226,LPP,0.0009523660633633,SCZ,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
229,229,CR1,0.0009487397404435,AD,ENSG00000203710,Tier 3A,CR1,1,207669492.0,207813992.0,1.0,complement component (3b/4b) receptor 1 (Knops blood group) [Source:HGNC Symbol;Acc:2334],8.0,1.0,1.0,1.0
231,231,JAK1,0.0009482063598069,MS,ENSG00000162434,Tier 1,JAK1,1,65298912.0,65432187.0,-1.0,Janus kinase 1 [Source:HGNC Symbol;Acc:6190],0.0,1.0,1.0,1.0
232,232,EPO,0.0009459959180448,SCZ,ENSG00000130427,Tier 3A,EPO,7,100318423.0,100321323.0,1.0,erythropoietin [Source:HGNC Symbol;Acc:3415],7.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,AD,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,AnorexiaNervosa,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,BipolarDisorder,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,MajorDepressiveDisorder,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,MigraineDisorder,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,OCD,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,SCZ,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,Tourette,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
237,237,ACE,0.0009372097661254,AD,ENSG00000159640,Tier 1,ACE,17,61554422.0,61599205.0,1.0,angiotensin I converting enzyme [Source:HGNC Symbol;Acc:2707],13.0,1.0,1.0,1.0
237,237,ACE,0.0009372097661254,SCZ,ENSG00000159640,Tier 1,ACE,17,61554422.0,61599205.0,1.0,angiotensin I converting enzyme [Source:HGNC Symbol;Acc:2707],13.0,1.0,1.0,1.0
238,238,CTSB,0.0009367857900797,AD,ENSG00000164733,Tier 1,CTSB,8,11700033.0,11726957.0,-1.0,cathepsin B [Source:HGNC Symbol;Acc:2527],0.0,1.0,1.0,1.0
238,238,CTSB,0.0009367857900797,PD,ENSG00000164733,Tier 1,CTSB,8,11700033.0,11726957.0,-1.0,cathepsin B [Source:HGNC Symbol;Acc:2527],0.0,1.0,1.0,1.0
240,240,IGF1R,0.0009279120642263,MigraineDisorder,ENSG00000140443,Tier 1,IGF1R,15,99192200.0,99507759.0,1.0,insulin-like growth factor 1 receptor [Source:HGNC Symbol;Acc:5465],4.0,1.0,1.0,1.0
241,241,SCARB1,0.0009274888946892,AD,ENSG00000073060,Tier 2,SCARB1,12,125261402.0,125367214.0,-1.0,"scavenger receptor class B, member 1 [Source:HGNC Symbol;Acc:1664]",6.0,1.0,1.0,1.0
244,244,IL12B,0.0009177789993131,MS,ENSG00000113302,Tier 1,IL12B,5,158741791.0,158757895.0,-1.0,"interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) [Source:HGNC Symbol;Acc:5970]",5.0,1.0,1.0,1.0
244,244,IL12B,0.0009177789993131,RestlessLeg,ENSG00000113302,Tier 1,IL12B,5,158741791.0,158757895.0,-1.0,"interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) [Source:HGNC Symbol;Acc:5970]",5.0,1.0,1.0,1.0
250,250,ALCAM,0.0008973130677721,RestlessLeg,ENSG00000170017,Tier 3B,ALCAM,3,105085753.0,105295744.0,1.0,activated leukocyte cell adhesion molecule [Source:HGNC Symbol;Acc:400],0.0,1.0,1.0,1.0
251,251,STK39,0.000892945607934,PD,ENSG00000198648,Tier 2,STK39,2,168810530.0,169104651.0,-1.0,serine threonine kinase 39 [Source:HGNC Symbol;Acc:17717],2.0,1.0,1.0,1.0
254,254,PSG7,0.0008665965039909,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
255,255,PSG9,0.0008665965039909,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
262,262,ADGRL2,0.0008584982383351,MigraineDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
262,262,ADGRL2,0.0008584982383351,OCD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
270,270,GDF10,0.0008436652451172,MS,ENSG00000107623,Tier 3B,GDF10,10,48425815.0,48438976.0,-1.0,growth differentiation factor 10 [Source:HGNC Symbol;Acc:4215],0.0,1.0,1.0,1.0
272,272,BMP3,0.0008436652451172,MigraineDisorder,ENSG00000152785,Tier 3A,BMP3,4,81952119.0,81978685.0,1.0,bone morphogenetic protein 3 [Source:HGNC Symbol;Acc:1070],0.0,1.0,1.0,1.0
281,281,FZD6,0.0008314378155227,RestlessLeg,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
287,287,BMP8A,0.0008060544202762,MigraineDisorder,ENSG00000183682,Tier 3A,BMP8A,1,39957318.0,39991607.0,1.0,bone morphogenetic protein 8a [Source:HGNC Symbol;Acc:21650],4.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,AD,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,AnorexiaNervosa,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,BipolarDisorder,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,MajorDepressiveDisorder,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,OCD,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,SCZ,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,Tourette,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
311,311,PRKCE,0.0007868160788171,AD,ENSG00000171132,Tier 1,PRKCE,2,45878484.0,46415129.0,1.0,"protein kinase C, epsilon [Source:HGNC Symbol;Acc:9401]",5.0,1.0,1.0,1.0
313,313,PLCE1,0.0007817483612876,MigraineDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
315,315,LILRB2,0.0007812984492249,AD,ENSG00000131042,Tier 3A,LILRB2,19,54777675.0,54785039.0,-1.0,"leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 [Source:HGNC Symbol;Acc:6606]",3.0,1.0,1.0,1.0
323,323,PTPRT,0.000772448913087,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
324,324,INHBA,0.0007709224685816,Epilepsy,ENSG00000122641,Tier 1,INHBA,7,41724712.0,41742706.0,-1.0,"inhibin, beta A [Source:HGNC Symbol;Acc:6066]",0.0,1.0,1.0,1.0
329,329,CD28,0.000759695350571,MigraineDisorder,ENSG00000178562,Tier 1,CD28,2,204571198.0,204603635.0,1.0,CD28 molecule [Source:HGNC Symbol;Acc:1653],2.0,1.0,1.0,1.0
329,329,CD28,0.000759695350571,MS,ENSG00000178562,Tier 1,CD28,2,204571198.0,204603635.0,1.0,CD28 molecule [Source:HGNC Symbol;Acc:1653],2.0,1.0,1.0,1.0
330,330,IL34,0.0007587237410397,AD,ENSG00000157368,Tier 3B,IL34,16,70613798.0,70694585.0,1.0,interleukin 34 [Source:HGNC Symbol;Acc:28529],0.0,1.0,1.0,1.0
335,335,PTK2,0.0007553397196923,RestlessLeg,ENSG00000169398,Tier 1,PTK2,8,141667999.0,142012315.0,-1.0,protein tyrosine kinase 2 [Source:HGNC Symbol;Acc:9611],0.0,1.0,1.0,1.0
336,336,PLXNA2,0.0007553210607118,RestlessLeg,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
350,350,PIK3CG,0.0007515267369575,AD,ENSG00000105851,Tier 1,PIK3CG,7,106505723.0,106547590.0,1.0,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma [Source:HGNC Symbol;Acc:8978]",0.0,1.0,1.0,1.0
357,357,NTRK2,0.000749608636934,MajorDepressiveDisorder,ENSG00000148053,Tier 1,NTRK2,9,87283466.0,87638505.0,1.0,"neurotrophic tyrosine kinase, receptor, type 2 [Source:HGNC Symbol;Acc:8032]",0.0,1.0,1.0,1.0
358,358,CAMK2D,0.0007485106339753,PD,ENSG00000145349,Tier 1,CAMK2D,4,114372188.0,114683083.0,-1.0,calcium/calmodulin-dependent protein kinase II delta [Source:HGNC Symbol;Acc:1462],1.0,1.0,1.0,1.0
360,360,EPHA4,0.0007480801123413,RestlessLeg,ENSG00000116106,Tier 1,EPHA4,2,222282747.0,222438922.0,-1.0,EPH receptor A4 [Source:HGNC Symbol;Acc:3388],0.0,1.0,1.0,1.0
366,366,CHL1,0.000745898087011,Epilepsy,ENSG00000134121,Tier 3A,CHL1,3,238279.0,451090.0,1.0,cell adhesion molecule L1-like [Source:HGNC Symbol;Acc:1939],0.0,1.0,1.0,1.0
374,374,TGFB2,0.0007333116437405,MS,ENSG00000092969,Tier 1,TGFB2,1,218519577.0,218617961.0,1.0,"transforming growth factor, beta 2 [Source:HGNC Symbol;Acc:11768]",7.0,1.0,1.0,1.0
396,396,SMPD3,0.0007226561239666,SCZ,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
397,397,ERBB3,0.0007221451583452,AnorexiaNervosa,ENSG00000065361,Tier 1,ERBB3,12,56473641.0,56497289.0,1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 [Source:HGNC Symbol;Acc:3431],17.0,1.0,1.0,1.0
406,406,TBK1,0.0007092890764613,ALS,ENSG00000183735,Tier 1,TBK1,12,64845660.0,64895888.0,1.0,TANK-binding kinase 1 [Source:HGNC Symbol;Acc:11584],0.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,AnorexiaNervosa,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,BipolarDisorder,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,MajorDepressiveDisorder,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,OCD,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,SCZ,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,Tourette,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
412,412,CHRNB4,0.0007031500366622,SCZ,ENSG00000117971,Tier 1,CHRNB4,15,78916461.0,79020096.0,-1.0,"cholinergic receptor, nicotinic, beta 4 (neuronal) [Source:HGNC Symbol;Acc:1964]",30.0,1.0,1.0,1.0
415,415,CD8A,0.0006975964257464,PSP,ENSG00000153563,Tier 3A,CD8A,2,87011729.0,87035519.0,-1.0,CD8a molecule [Source:HGNC Symbol;Acc:1706],1.0,1.0,1.0,1.0
416,416,IL10,0.0006962279074699,Epilepsy,ENSG00000136634,Tier 1,IL10,1,206940947.0,206945839.0,-1.0,interleukin 10 [Source:HGNC Symbol;Acc:5962],10.0,1.0,1.0,1.0
421,421,LDLR,0.0006872866179625,AD,ENSG00000130164,Tier 2,LDLR,19,11200038.0,11244492.0,1.0,low density lipoprotein receptor [Source:HGNC Symbol;Acc:6547],21.0,1.0,1.0,1.0
432,432,GRM5,0.000649089175245,BipolarDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,1.0,1.0
432,432,GRM5,0.000649089175245,MajorDepressiveDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,1.0,1.0
434,434,ROBO1,0.0006436471954033,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
434,434,ROBO1,0.0006436471954033,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
434,434,ROBO1,0.0006436471954033,MigraineDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
435,435,FGFR1,0.0006352084682274,BipolarDisorder,ENSG00000077782,Tier 1,FGFR1,8,38268656.0,38326352.0,-1.0,fibroblast growth factor receptor 1 [Source:HGNC Symbol;Acc:3688],1.0,1.0,1.0,1.0
435,435,FGFR1,0.0006352084682274,SCZ,ENSG00000077782,Tier 1,FGFR1,8,38268656.0,38326352.0,-1.0,fibroblast growth factor receptor 1 [Source:HGNC Symbol;Acc:3688],1.0,1.0,1.0,1.0
435,435,FGFR1,0.0006352084682274,Tourette,ENSG00000077782,Tier 1,FGFR1,8,38268656.0,38326352.0,-1.0,fibroblast growth factor receptor 1 [Source:HGNC Symbol;Acc:3688],1.0,1.0,1.0,1.0
440,440,DAG1,0.0006264769230192,MajorDepressiveDisorder,ENSG00000173402,Tier 3B,DAG1,3,49506146.0,49573048.0,1.0,dystroglycan 1 (dystrophin-associated glycoprotein 1) [Source:HGNC Symbol;Acc:2666],11.0,1.0,1.0,1.0
444,444,NXPH1,0.0006254289858384,SCZ,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
445,445,RPH3A,0.0006254289858384,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
445,445,RPH3A,0.0006254289858384,Epilepsy,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
446,446,NLGN4X,0.0006254289858384,SCZ,ENSG00000146938,Tier 3B,NLGN4X,X,5758678.0,6146904.0,-1.0,"neuroligin 4, X-linked [Source:HGNC Symbol;Acc:14287]",1.0,1.0,1.0,1.0
454,454,NRXN3,0.0005906912074416,SCZ,ENSG00000021645,Tier 3A,NRXN3,14,78708734.0,80330762.0,1.0,neurexin 3 [Source:HGNC Symbol;Acc:8010],4.0,1.0,1.0,1.0
470,470,LILRA5,0.0005494418709892,AD,ENSG00000187116,Tier 3A,LILRA5,19,54818353.0,54824409.0,-1.0,"leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 [Source:HGNC Symbol;Acc:16309]",0.0,1.0,1.0,1.0
478,478,PVRIG,0.0005408898944529,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
479,479,PARD3,0.0005408898944529,RestlessLeg,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
481,481,PVR,0.0005408898944529,MS,ENSG00000073008,Tier 3A,PVR,19,45147098.0,45166850.0,1.0,poliovirus receptor [Source:HGNC Symbol;Acc:9705],0.0,1.0,1.0,1.0
492,492,GALR1,0.0005178884384831,MajorDepressiveDisorder,ENSG00000166573,Tier 3A,GALR1,18,74962505.0,74980858.0,1.0,galanin receptor 1 [Source:HGNC Symbol;Acc:4132],0.0,1.0,1.0,1.0
503,503,IFNA6,0.0005152723102474,Epilepsy,ENSG00000120235,Tier 1,IFNA6,9,21349834.0,21351377.0,-1.0,"interferon, alpha 6 [Source:HGNC Symbol;Acc:5427]",0.0,1.0,1.0,1.0
518,518,BMP2,0.0005076674145674,MajorDepressiveDisorder,ENSG00000125845,Tier 3A,BMP2,20,6748311.0,6760927.0,1.0,bone morphogenetic protein 2 [Source:HGNC Symbol;Acc:1069],1.0,1.0,1.0,1.0
526,526,JAG1,0.0005065027767996,MajorDepressiveDisorder,ENSG00000101384,Tier 3A,JAG1,20,10618332.0,10654694.0,-1.0,jagged 1 [Source:HGNC Symbol;Acc:6188],1.0,1.0,1.0,1.0
526,526,JAG1,0.0005065027767996,MigraineDisorder,ENSG00000101384,Tier 3A,JAG1,20,10618332.0,10654694.0,-1.0,jagged 1 [Source:HGNC Symbol;Acc:6188],1.0,1.0,1.0,1.0
531,531,INHBE,0.0005030356924652,SCZ,ENSG00000139269,Tier 3A,INHBE,12,57846106.0,57853063.0,1.0,"inhibin, beta E [Source:HGNC Symbol;Acc:24029]",0.0,1.0,1.0,1.0
573,573,IDE,0.0004941124828182,ALS,ENSG00000119912,Tier 2,IDE,10,94211441.0,94333833.0,-1.0,insulin-degrading enzyme [Source:HGNC Symbol;Acc:5381],10.0,1.0,1.0,1.0
588,588,LTBR,0.0004919183509912,MS,ENSG00000111321,Tier 1,LTBR,12,6484211.0,6500733.0,1.0,"lymphotoxin beta receptor (TNFR superfamily, member 3) [Source:HGNC Symbol;Acc:6718]",1.0,1.0,1.0,1.0
589,589,LILRB5,0.0004914003997622,AD,ENSG00000105609,Tier 3A,LILRB5,19,54754263.0,54761164.0,-1.0,"leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 [Source:HGNC Symbol;Acc:6609]",1.0,1.0,1.0,1.0
593,593,CNTNAP2,0.0004911184456382,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
594,594,TYR,0.0004827707179102,MajorDepressiveDisorder,ENSG00000077498,Tier 1,TYR,11,88910620.0,89028927.0,1.0,tyrosinase [Source:HGNC Symbol;Acc:12442],11.0,1.0,1.0,1.0
596,596,HAVCR2,0.0004791571903772,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
597,597,LRRC4B,0.0004710390161371,SCZ,ENSG00000131409,Tier 3B,LRRC4B,19,51020149.0,51071302.0,-1.0,leucine rich repeat containing 4B [Source:HGNC Symbol;Acc:25042],0.0,1.0,1.0,1.0
619,619,IL12RB2,0.0004669917545721,Epilepsy,ENSG00000081985,Tier 3B,IL12RB2,1,67773047.0,67862583.0,1.0,"interleukin 12 receptor, beta 2 [Source:HGNC Symbol;Acc:5972]",2.0,1.0,1.0,1.0
620,620,ATP2A2,0.0004664559360162,MajorDepressiveDisorder,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
620,620,ATP2A2,0.0004664559360162,SCZ,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
626,626,NPPB,0.000466214432254,MajorDepressiveDisorder,ENSG00000120937,Tier 3A,NPPB,1,11917521.0,11918988.0,-1.0,natriuretic peptide B [Source:HGNC Symbol;Acc:7940],1.0,1.0,1.0,1.0
627,627,ADCYAP1,0.000466214432254,RestlessLeg,ENSG00000141433,Tier 3A,ADCYAP1,18,904944.0,912173.0,1.0,adenylate cyclase activating polypeptide 1 (pituitary) [Source:HGNC Symbol;Acc:241],0.0,1.0,1.0,1.0
628,628,PAM,0.000466214432254,RestlessLeg,ENSG00000145730,Tier 2,PAM,5,102089685.0,102366809.0,1.0,peptidylglycine alpha-amidating monooxygenase [Source:HGNC Symbol;Acc:8596],0.0,1.0,1.0,1.0
628,628,PAM,0.000466214432254,SCZ,ENSG00000145730,Tier 2,PAM,5,102089685.0,102366809.0,1.0,peptidylglycine alpha-amidating monooxygenase [Source:HGNC Symbol;Acc:8596],0.0,1.0,1.0,1.0
630,630,ETV5,0.0004661799988689,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
638,638,HBEGF,0.0004652219450999,AD,ENSG00000113070,Tier 1,HBEGF,5,139712428.0,139726216.0,-1.0,heparin-binding EGF-like growth factor [Source:HGNC Symbol;Acc:3059],0.0,1.0,1.0,1.0
641,641,ATP2B1,0.0004647749531563,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
641,641,ATP2B1,0.0004647749531563,MigraineDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
648,648,CDH10,0.0004626361236933,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
654,654,FCN1,0.0004614288380923,MajorDepressiveDisorder,ENSG00000085265,Tier 3B,FCN1,9,137801431.0,137809809.0,-1.0,ficolin (collagen/fibrinogen domain containing) 1 [Source:HGNC Symbol;Acc:3623],0.0,1.0,1.0,1.0
655,655,MDK,0.0004614288380923,AnorexiaNervosa,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
655,655,MDK,0.0004614288380923,BipolarDisorder,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
655,655,MDK,0.0004614288380923,MajorDepressiveDisorder,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
655,655,MDK,0.0004614288380923,MigraineDisorder,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
655,655,MDK,0.0004614288380923,OCD,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
655,655,MDK,0.0004614288380923,SCZ,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
655,655,MDK,0.0004614288380923,Tourette,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
684,684,TRPC4,0.0004597414579143,SCZ,ENSG00000133107,Tier 3A,TRPC4,13,38210773.0,38444562.0,-1.0,"transient receptor potential cation channel, subfamily C, member 4 [Source:HGNC Symbol;Acc:12336]",0.0,1.0,1.0,1.0
687,687,TXK,0.0004597414579143,MS,ENSG00000074966,Tier 1,TXK,4,48068410.0,48136273.0,-1.0,TXK tyrosine kinase [Source:HGNC Symbol;Acc:12434],0.0,1.0,1.0,1.0
705,705,AATK,0.0004597414579143,MajorDepressiveDisorder,ENSG00000181409,Tier 3A,AATK,17,79091095.0,79139877.0,-1.0,apoptosis-associated tyrosine kinase [Source:HGNC Symbol;Acc:21],0.0,1.0,1.0,1.0
715,715,FCGR2B,0.0004597414579143,PD,ENSG00000072694,Tier 1,FCGR2B,1,161551101.0,161648444.0,1.0,"Fc fragment of IgG, low affinity IIb, receptor (CD32) [Source:HGNC Symbol;Acc:3618]",2.0,1.0,1.0,1.0
715,715,FCGR2B,0.0004597414579143,SCZ,ENSG00000072694,Tier 1,FCGR2B,1,161551101.0,161648444.0,1.0,"Fc fragment of IgG, low affinity IIb, receptor (CD32) [Source:HGNC Symbol;Acc:3618]",2.0,1.0,1.0,1.0
720,720,GRM1,0.0004597414579143,SCZ,ENSG00000152822,Tier 1,GRM1,6,146348782.0,146758734.0,1.0,"glutamate receptor, metabotropic 1 [Source:HGNC Symbol;Acc:4593]",0.0,1.0,1.0,1.0
745,745,CD5,0.0004597414579143,MS,ENSG00000110448,Tier 1,CD5,11,60869867.0,60895324.0,1.0,CD5 molecule [Source:HGNC Symbol;Acc:1685],0.0,1.0,1.0,1.0
752,752,NOX4,0.0004597414579143,AD,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
763,763,PRKCQ,0.0004597414579143,AD,ENSG00000065675,Tier 1,PRKCQ,10,6469105.0,6622263.0,-1.0,"protein kinase C, theta [Source:HGNC Symbol;Acc:9410]",1.0,1.0,1.0,1.0
765,765,MST1R,0.0004597414579143,SCZ,ENSG00000164078,Tier 1,MST1R,3,49924435.0,49941299.0,-1.0,macrophage stimulating 1 receptor (c-met-related tyrosine kinase) [Source:HGNC Symbol;Acc:7381],3.0,1.0,1.0,1.0
773,773,CEACAM19,0.000456935911378,MS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
774,774,SMPD2,0.000456905040935,AD,ENSG00000135587,Tier 2,SMPD2,6,109761966.0,109765122.0,1.0,"sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase) [Source:HGNC Symbol;Acc:11121]",1.0,1.0,1.0,1.0
777,777,MAPK10,0.000456905040935,AD,ENSG00000109339,Tier 1,MAPK10,4,86936276.0,87515284.0,-1.0,mitogen-activated protein kinase 10 [Source:HGNC Symbol;Acc:6872],0.0,1.0,1.0,1.0
781,781,MAP2K5,0.000456905040935,BipolarDisorder,ENSG00000137764,Tier 1,MAP2K5,15,67835047.0,68099461.0,1.0,mitogen-activated protein kinase kinase 5 [Source:HGNC Symbol;Acc:6845],7.0,1.0,1.0,1.0
781,781,MAP2K5,0.000456905040935,RestlessLeg,ENSG00000137764,Tier 1,MAP2K5,15,67835047.0,68099461.0,1.0,mitogen-activated protein kinase kinase 5 [Source:HGNC Symbol;Acc:6845],7.0,1.0,1.0,1.0
785,785,LPA,0.0004565373904151,MajorDepressiveDisorder,ENSG00000198670,Tier 3A,LPA,6,160952515.0,161087407.0,-1.0,"lipoprotein, Lp(a) [Source:HGNC Symbol;Acc:6667]",21.0,1.0,1.0,1.0
795,795,EPHA7,0.0004553765163423,RestlessLeg,ENSG00000135333,Tier 1,EPHA7,6,93949738.0,94129265.0,-1.0,EPH receptor A7 [Source:HGNC Symbol;Acc:3390],0.0,1.0,1.0,1.0
802,802,PRKAA1,0.0004425399982963,MS,ENSG00000132356,Tier 1,PRKAA1,5,40759481.0,40798476.0,-1.0,"protein kinase, AMP-activated, alpha 1 catalytic subunit [Source:HGNC Symbol;Acc:9376]",1.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,AD,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,AnorexiaNervosa,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,BipolarDisorder,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,Epilepsy,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,MajorDepressiveDisorder,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,OCD,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,SCZ,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,Tourette,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
812,812,PLK2,0.0004410516180627,SCZ,ENSG00000145632,Tier 2,PLK2,5,57749809.0,57756087.0,-1.0,polo-like kinase 2 [Source:HGNC Symbol;Acc:19699],0.0,1.0,1.0,1.0
818,818,ITGA1,0.0004390584625554,SCZ,ENSG00000213949,Tier 3A,ITGA1,5,52083730.0,52255040.0,1.0,"integrin, alpha 1 [Source:HGNC Symbol;Acc:6134]",1.0,1.0,1.0,1.0
819,819,ITGA2B,0.0004390584625554,AD,ENSG00000005961,Tier 1,ITGA2B,17,42449548.0,42466873.0,-1.0,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) [Source:HGNC Symbol;Acc:6138]",1.0,1.0,1.0,1.0
819,819,ITGA2B,0.0004390584625554,PD,ENSG00000005961,Tier 1,ITGA2B,17,42449548.0,42466873.0,-1.0,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) [Source:HGNC Symbol;Acc:6138]",1.0,1.0,1.0,1.0
827,827,SEMA3F,0.0004378740066682,AD,ENSG00000001617,Tier 3B,SEMA3F,3,50192478.0,50226508.0,1.0,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F [Source:HGNC Symbol;Acc:10728]",3.0,1.0,1.0,1.0
829,829,SEMA3E,0.0004378740066682,MajorDepressiveDisorder,ENSG00000170381,Tier 3B,SEMA3E,7,82993222.0,83278326.0,-1.0,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E [Source:HGNC Symbol;Acc:10727]",0.0,1.0,1.0,1.0
831,831,SEMA3C,0.0004378740066682,AD,ENSG00000075223,Tier 3A,SEMA3C,7,80371854.0,80551675.0,-1.0,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C [Source:HGNC Symbol;Acc:10725]",1.0,1.0,1.0,1.0
832,832,VEGFB,0.0004378740066682,MS,ENSG00000173511,Tier 1,VEGFB,11,64002010.0,64006259.0,1.0,vascular endothelial growth factor B [Source:HGNC Symbol;Acc:12681],1.0,1.0,1.0,1.0
834,834,SPON1,0.0004367555788455,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
840,840,PRL,0.0004338773437107,MigraineDisorder,ENSG00000172179,Tier 3A,PRL,6,22287480.0,22297730.0,-1.0,prolactin [Source:HGNC Symbol;Acc:9445],0.0,1.0,1.0,1.0
842,842,ADCY2,0.0004338204363955,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
842,842,ADCY2,0.0004338204363955,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
842,842,ADCY2,0.0004338204363955,SCZ,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
844,844,DYRK1A,0.0004335731888428,PD,ENSG00000157540,Tier 1,DYRK1A,21,38738092.0,38889753.0,1.0,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A [Source:HGNC Symbol;Acc:3091],0.0,1.0,1.0,1.0
848,848,SLC9A8,0.0004284279468102,ALS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
871,871,TSLP,0.0004168373845001,MajorDepressiveDisorder,ENSG00000145777,Tier 1,TSLP,5,110405760.0,110413722.0,1.0,thymic stromal lymphopoietin [Source:HGNC Symbol;Acc:30743],5.0,1.0,1.0,1.0
872,872,IL7,0.0004168373845001,MS,ENSG00000104432,Tier 3A,IL7,8,79587978.0,79717758.0,-1.0,interleukin 7 [Source:HGNC Symbol;Acc:6023],0.0,1.0,1.0,1.0
875,875,AKT3,0.0004160165398302,AnorexiaNervosa,ENSG00000117020,Tier 1,AKT3,1,243651535.0,244014381.0,-1.0,v-akt murine thymoma viral oncogene homolog 3 [Source:HGNC Symbol;Acc:393],1.0,1.0,1.0,1.0
875,875,AKT3,0.0004160165398302,SCZ,ENSG00000117020,Tier 1,AKT3,1,243651535.0,244014381.0,-1.0,v-akt murine thymoma viral oncogene homolog 3 [Source:HGNC Symbol;Acc:393],1.0,1.0,1.0,1.0
876,876,LRP4,0.0004155049640105,MigraineDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
879,879,SRPK2,0.0004113727537413,AnorexiaNervosa,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
879,879,SRPK2,0.0004113727537413,BipolarDisorder,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
879,879,SRPK2,0.0004113727537413,MajorDepressiveDisorder,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
879,879,SRPK2,0.0004113727537413,OCD,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
879,879,SRPK2,0.0004113727537413,SCZ,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
879,879,SRPK2,0.0004113727537413,Tourette,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
884,884,TMED5,0.0003914333484093,PD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
889,889,LTBP3,0.000383341996137,MajorDepressiveDisorder,ENSG00000168056,Tier 3A,LTBP3,11,65306276.0,65326401.0,-1.0,latent transforming growth factor beta binding protein 3 [Source:HGNC Symbol;Acc:6716],3.0,1.0,1.0,1.0
897,897,NPNT,0.0003678877676139,MajorDepressiveDisorder,ENSG00000168743,Tier 3A,NPNT,4,106815932.0,106925184.0,1.0,nephronectin [Source:HGNC Symbol;Acc:27405],3.0,1.0,1.0,1.0
